These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18199625)

  • 1. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
    Kyuma M; Nakata T; Hashimoto A; Nagao K; Sasao H; Takahashi T; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2004 Feb; 45(2):155-63. PubMed ID: 14960630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
    Nishisato K; Hashimoto A; Nakata T; Doi T; Yamamoto H; Nagahara D; Shimoshige S; Yuda S; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2010 Aug; 51(8):1241-9. PubMed ID: 20679471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
    Levine YC; Rosenberg MA; Mittleman M; Samuel M; Methachittiphan N; Link M; Josephson ME; Buxton AE
    Heart Rhythm; 2014 Jul; 11(7):1109-16. PubMed ID: 24837348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
    Kawai T; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Am J Cardiol; 2015 Jun; 115(11):1549-54. PubMed ID: 25851796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
    Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
    Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
    Nakata T; Wakabayashi T; Kyuma M; Takahashi T; Tsuchihashi K; Shimamoto K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):186-94. PubMed ID: 15452671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
    Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.
    Al Badarin FJ; Wimmer AP; Kennedy KF; Jacobson AF; Bateman TM
    J Nucl Cardiol; 2014 Aug; 21(4):756-62; quiz 753-55, 763-5. PubMed ID: 25015681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of follow-up cardiac metaiodobenzylguanidine imaging on left ventricular trajectory after acute decompensation.
    Kayama K; Yamada T; Seo M; Watanabe T; Morita T; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1144-1154. PubMed ID: 38483956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.